• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

女性在非侵入性产前检测(唐氏综合征筛查)中的选择:英国引入前某单一中心的结果。

Women's choices in non-invasive prenatal testing for aneuploidy screening: results from a single centre prior to introduction in England.

机构信息

Department of Maternal and Fetal Medicine, University College London Institute for Women's Health, London, UK.

Fetal Medicine Unit, University College London Hospitals NHS Foundation Trust, London, UK.

出版信息

Arch Dis Child. 2020 Jan;105(1):47-52. doi: 10.1136/archdischild-2019-317031. Epub 2019 Jun 26.

DOI:10.1136/archdischild-2019-317031
PMID:31243005
Abstract

OBJECTIVE

To evaluate patient choices and uptake of non-invasive prenatal testing (NIPT) for aneuploidy screening offered in a contingency model as part of routine care.

METHOD

We retrospectively reviewed data for all women with a singleton pregnancy attending for routine first trimester screening over an 18-month period. Women with a 'high-chance' of trisomy 21, 18 or 13 (≥1:150) were offered the choice of no further testing, NIPT or invasive testing, in line with the screening pathway recommended by the UK National Screening Committee.

RESULTS

Of 9342 women attending for a first trimester ultrasound scan, 7939 women were included in this study. Of these, 352 had a high-chance screening result for trisomy 21, and 291 (82.7%) opted for NIPT. The proportion of women opting for NIPT decreased as the chance of trisomy 21 increased: uptake was 93.2%, 90.0%, 77.1% and 47.2% for women with a chance of 1:100-150, 1:50-99, 1:10-49 and >1:10, respectively. 516 women (5.5%) accessed primary NIPT screening in the private sector, and 638 women (6.8%) declined any aneuploidy screening or testing.

CONCLUSION

Implementation of NIPT testing in a contingency model has a high uptake in a non-research National Health Service setting; the rate of uptake is related to the combined test risk result.

摘要

目的

评估在应急模式下提供的非侵入性产前检测(NIPT)用于非整倍体筛查的患者选择和接受情况,该检测作为常规护理的一部分。

方法

我们回顾性分析了在 18 个月的时间内,所有接受常规早孕期筛查的单胎妊娠女性的数据。对于三体 21、18 或 13 (≥1:150)的“高风险”女性,根据英国国家筛查委员会推荐的筛查途径,提供不进行进一步检测、NIPT 或侵入性检测的选择。

结果

在 9342 名接受早孕期超声扫描的女性中,有 7939 名女性纳入本研究。其中,352 名女性的三体 21 筛查结果为高风险,291 名(82.7%)选择了 NIPT。选择 NIPT 的女性比例随着三体 21 的可能性增加而降低:风险为 1:100-150、1:50-99、1:10-49 和>1:10 的女性中,NIPT 的接受率分别为 93.2%、90.0%、77.1%和 47.2%。516 名女性(5.5%)在私立部门接受了初级 NIPT 筛查,638 名女性(6.8%)拒绝任何非整倍体筛查或检测。

结论

在非研究性的国民保健制度环境中,以应急模式实施 NIPT 检测具有较高的接受率;接受率与联合检测风险结果有关。

相似文献

1
Women's choices in non-invasive prenatal testing for aneuploidy screening: results from a single centre prior to introduction in England.女性在非侵入性产前检测(唐氏综合征筛查)中的选择:英国引入前某单一中心的结果。
Arch Dis Child. 2020 Jan;105(1):47-52. doi: 10.1136/archdischild-2019-317031. Epub 2019 Jun 26.
2
Cytogenomic results following high-chance non-invasive prenatal testing: a UK national audit.高风险无创性产前检测后的细胞基因组学结果:英国国家审计。
Genet Res (Camb). 2020 Sep 1;102:e7. doi: 10.1017/S0016672320000087.
3
National data on the early clinical use of non-invasive prenatal testing in public and private healthcare in Denmark 2013-2017.丹麦 2013-2017 年公共和私人医疗保健中无创性产前检测的早期临床应用的国家数据。
Acta Obstet Gynecol Scand. 2021 May;100(5):884-892. doi: 10.1111/aogs.14052. Epub 2021 Feb 24.
4
Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.在国民医疗服务体系地区遗传学实验室中实施基于游离DNA的无创产前检测
Genet Res (Camb). 2019 Dec 9;101:e11. doi: 10.1017/S0016672319000119.
5
A study on non-invasive prenatal screening for the detection of aneuploidy.一项关于非侵入性产前筛查检测非整倍体的研究。
Ginekol Pol. 2022;93(9):716-720. doi: 10.5603/GP.a2021.0254. Epub 2022 Mar 22.
6
Evaluation of non-invasive prenatal testing (NIPT) for aneuploidy in an NHS setting: a reliable accurate prenatal non-invasive diagnosis (RAPID) protocol.英国国家医疗服务体系(NHS)环境下非侵入性产前检测(NIPT)用于检测非整倍体的评估:一项可靠准确的产前非侵入性诊断(RAPID)方案。
BMC Pregnancy Childbirth. 2014 Jul 16;14:229. doi: 10.1186/1471-2393-14-229.
7
Implementation of non-invasive prenatal testing within a national UK antenatal screening programme: Impact on women's choices.在英国全国产前筛查计划中实施无创产前检测:对女性选择的影响。
Prenat Diagn. 2022 May;42(5):549-556. doi: 10.1002/pd.6131. Epub 2022 Mar 24.
8
Noninvasive prenatal testing in routine clinical practice--an audit of NIPT and combined first-trimester screening in an unselected Australian population.常规临床实践中的无创产前检测——对澳大利亚未选择人群中无创产前检测和孕早期联合筛查的一项审计
Aust N Z J Obstet Gynaecol. 2016 Feb;56(1):22-8. doi: 10.1111/ajo.12432.
9
Prenatal screening for fetal aneuploidy in singleton pregnancies.单胎妊娠胎儿非整倍体的产前筛查。
J Obstet Gynaecol Can. 2011 Jul;33(7):736-750. doi: 10.1016/S1701-2163(16)34961-1.
10
Evaluation of the Z-score accuracy of noninvasive prenatal testing for fetal trisomies 13, 18 and 21 at a single center.单中心无创性产前检测胎儿 13、18 和 21 三体的 Z 评分准确性评估。
Prenat Diagn. 2021 May;41(6):690-696. doi: 10.1002/pd.5908. Epub 2021 Feb 11.

引用本文的文献

1
Cytogenomic results following high-chance non-invasive prenatal testing: a UK national audit.高风险无创性产前检测后的细胞基因组学结果:英国国家审计。
Genet Res (Camb). 2020 Sep 1;102:e7. doi: 10.1017/S0016672320000087.